• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Diabetes is a risk factor for high platelet reactivity post percutaneous coronary intervention

byKeerthana PasumarthiandAlex Chan
December 26, 2022
in Cardiology, Chronic Disease, Endocrinology, Hematology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In patients with diabetes mellitus who are on therapy with clopidogrel following percutaneous coronary intervention, high platelet reactivity was more frequent compared to those without diabetes mellitus

2. Patients with diabetes mellitus had an increased risk of major adverse cardiac events compared to those without diabetes mellitus

3. Patients with insulin-dependent diabetes mellitus had an increased incidence of major adverse cardiac events compared to patients with non-insulin-dependent diabetes mellitus 

Evidence Rating Level: 2 (Good) 

Diabetes mellitus and high platelet reactivity (HPR) on clopidogrel are known to be associated with an increased risk of ischemic events following percutaneous coronary intervention (PCI). Studies have demonstrated that in patients with diabetes mellitus, there is a higher prevalence of HPR; however, the association between HPR and thromboembolic events in unknown. In this prospective cohort study, 8582 patients undergoing PCI with drug-eluting stents, loaded with aspirin and clopidogrel were included. Platelet reactivity was assessed after successful PCI using the VerifyNow Aspirin, P2Y12, and IIb/IIa assays. The primary endpoint in this study was definite or probable stent thrombosis. Out of all the patients included in the ADAPT-DES study, 2429 (28.3%) had diabetes mellitus. The results of this study showed that patients with diabetes mellitus had significantly higher mean P2Y12 reaction units than patients without diabetes mellitus, and the frequency of HPR was higher in patients with diabetes mellitus (56.8% vs 37.2%). The increase in HPR in patients with diabetes mellitus was associated with a higher incidence of major adverse cardiac events (aHR 1.44, 95%CI 1.07-1.93). Interestingly, patients with insulin-dependent diabetes mellitus (IDDM) had higher rates of MACE compared with those with non-insulin dependent diabetes mellitus (NIDDM) (aHR 1.02, 95%CI 0.70-1.50; and aHR 2.28, 95%CI 1.39-3.73, respectively). In conclusion, high platelet reactivity was more common amongst patients with diabetes mellitus and was associated with an increased incidence of adverse events. There are several limitations of this study that should be noted. Firstly, individuals with IDDM versus NIDDM may have different therapies such as the use of SGLT2-inhibitors (sodium-glucose cotransporter 2) which can affect cardiovascular health and impact the interpretation of these findings. Additionally, testing for platelet reactivity in this study was only conducted at one time point but this may vary throughout the disease process. Nevertheless, these findings warrant further investigation into variations in ischemic outcomes between NIDDM and IDDM patients, as well as whether diabetics could benefit from increased platelet reactivity testing and different anti-platelet therapy overall. 

Click to read the study in JAHA

Image: PD

RELATED REPORTS

Metformin use in Type 2 Diabetes associated with decreased risk of joint replacement

Low-carbohydrate, high-fat diet improves glycemic control in type 2 diabetic patients

Dapagliflozin reduces the risk of hospitalization in patients with chronic kidney disease

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: diabetesPCIplatelet reactivitySTEMIthrombosis
Previous Post

Weekly semaglutide associated with reduced BMI in adolescents with obesity

Next Post

Vitamin C supplementation in pregnant smokers leads to improved airway function in offspring

RelatedReports

Type 2 diabetes associated with reduction in disability-free life years
Chronic Disease

Metformin use in Type 2 Diabetes associated with decreased risk of joint replacement

January 16, 2023
Pediatric DKA associated with recent acute care visits
Cardiology

Low-carbohydrate, high-fat diet improves glycemic control in type 2 diabetic patients

January 11, 2023
Solitary kidney not associated with contrast-induced nephropathy
Chronic Disease

Dapagliflozin reduces the risk of hospitalization in patients with chronic kidney disease

December 26, 2022
Improved glycemic control in type 1 diabetics on very low-carbohydrate diets
Cardiology

Patient-supporter training improved patient confidence in managing diabetes

December 23, 2022
Next Post
2 Minute Rewind November 29, 2021

Vitamin C supplementation in pregnant smokers leads to improved airway function in offspring

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: the Future of Medicine, Neuralink, the Spotlight on Celine Dion and COVID-19 on Social Media

Ultrasound screening for AAAs has no effect on all-cause mortality

Comparison of resuscitative endovascular balloon occlusion of the aorta versus resuscitative thoracotomy for aortic occlusion

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Chronic obstructive pulmonary disease associated with worse postoperative outcomes
  • Empagliflozin use is associated with slower progression of chronic kidney disease
  • Diagnostic tool may help identify cerebral palsy regardless of encephalopathy features
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options